Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI could help decide when to start rehab after surgery

NCT ID NCT07406269

First seen Feb 19, 2026 · Last updated Jun 22, 2026 · Updated 19 times

Summary

This study tests an artificial intelligence tool that helps doctors decide when patients can safely begin rehabilitation after gastrointestinal or cancer surgery. The tool analyzes routine hospital data to predict which patients are ready for early recovery steps. Researchers will study how well the tool works and how it can be used safely in practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Erasmus MC, University Medical Center Rotterdam

    Rotterdam, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-based clinical decision support system (DESIRE)

What this could lead to

If successful, this tool could help doctors make safer, faster decisions about when to start rehabilitation after surgery, potentially reducing hospital stays and complications.

What could go wrong

This is an early-stage study with only 103 participants, so results may not apply to all patients. The AI tool is not a replacement for clinical judgment and may not reduce risks in all cases.

Conditions

The condition(s) this trial relates to.

digestive system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.